Entelexo Biotherapeutics

Creating a New Class of Drugs to Address Incurable Autoimmune Diseases

·Health & Fitness·YC Winter 2021·tracked since Sep 25, 2026
WatchVisit site ↗
Monthly revenue–Not shared yet
Rank–Unranked
Last 30 days–Growth in MRR
Revenue per founder–– founders

About Entelexo Biotherapeutics

Entelexo is creating modern treatments for immune-mediated diseases, such as psoriasis, using novel engineered exosome technology.

Discover more startups

Browse the board →